MetLife, Inc. (NYSE:MET) Shares Sold by Catalyst Capital Advisors LLC

Catalyst Capital Advisors LLC cut its position in shares of MetLife, Inc. (NYSE:METFree Report) by 70.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 1,088 shares of the financial services provider’s stock after selling 2,617 shares during the quarter. Catalyst Capital Advisors LLC’s holdings in MetLife were worth $89,000 as of its most recent filing with the SEC.

Other hedge funds also recently modified their holdings of the company. PFG Investments LLC grew its holdings in shares of MetLife by 8.9% in the 3rd quarter. PFG Investments LLC now owns 6,360 shares of the financial services provider’s stock worth $525,000 after acquiring an additional 520 shares during the last quarter. CX Institutional grew its holdings in shares of MetLife by 15.9% in the 4th quarter. CX Institutional now owns 68,005 shares of the financial services provider’s stock worth $5,568,000 after acquiring an additional 9,337 shares during the last quarter. B. Metzler seel. Sohn & Co. Holding AG acquired a new position in shares of MetLife in the 3rd quarter worth $2,960,000. Meeder Asset Management Inc. grew its holdings in shares of MetLife by 48,101.4% in the 3rd quarter. Meeder Asset Management Inc. now owns 106,043 shares of the financial services provider’s stock worth $8,746,000 after acquiring an additional 105,823 shares during the last quarter. Finally, Segall Bryant & Hamill LLC acquired a new position in shares of MetLife in the 3rd quarter worth $1,074,000. 94.99% of the stock is currently owned by institutional investors and hedge funds.

MetLife Price Performance

MET opened at $82.31 on Wednesday. The stock has a market cap of $57.00 billion, a price-to-earnings ratio of 13.79, a PEG ratio of 0.64 and a beta of 1.07. MetLife, Inc. has a 1 year low of $67.30 and a 1 year high of $89.05. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.54. The stock has a fifty day moving average price of $83.40 and a 200 day moving average price of $81.15.

MetLife (NYSE:METGet Free Report) last released its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. Analysts forecast that MetLife, Inc. will post 9.63 EPS for the current fiscal year.

MetLife Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th will be issued a dividend of $0.545 per share. The ex-dividend date is Tuesday, February 4th. This represents a $2.18 annualized dividend and a yield of 2.65%. MetLife’s dividend payout ratio (DPR) is currently 36.52%.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on MET shares. Wells Fargo & Company decreased their target price on MetLife from $93.00 to $92.00 and set an “overweight” rating on the stock in a report on Tuesday, January 14th. TD Cowen lifted their target price on MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a report on Wednesday, November 27th. JPMorgan Chase & Co. raised their target price on MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 7th. BMO Capital Markets started coverage on MetLife in a research report on Thursday, January 23rd. They issued a “market perform” rating and a $97.00 target price for the company. Finally, Barclays decreased their target price on MetLife from $96.00 to $95.00 and set an “overweight” rating for the company in a research report on Friday, February 7th. Two investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $92.17.

Read Our Latest Stock Report on MetLife

MetLife Company Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

See Also

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.